Gastrointestinal Tolerance And General Health Status Of Healthy Term Infants Fed A New Infant Formula

December 23, 2013 updated by: Nestlé

Gastrointestinal Tolerance And General Health Status Of Healthy Term Infants Fed A New Infant Formula: A Prospective, Observational Cohort Study In China

The purpose of this study is to assess stool consistency, in combination with additional health-related parameters including gastrointestinal tolerance and health-related quality of life, in a large sample of Chinese infants. We will also assess the timing of, frequency, and reasons for changes in the choice of formula or method of feeding among infants in this sample, as well as incidence of common infant illness and associated healthcare usage. Anthropometric measures and the frequency and duration of physician- and parent-reported gastrointestinal and other adverse events will be evaluated.

Study Overview

Detailed Description

Parents / legally acceptable representatives of eligible infants will be invited to volunteer.

Study Type

Observational

Enrollment (Actual)

460

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Beijing, China
        • Peking University First Hospital
      • Beijing, China
        • Beijing Obstetrics Gynecology Hospital
      • Shanghai, China
        • Children's Hospital of Fudan University
      • Shanghai, China, 200127
        • Shanghai Children's Medical Center Affiliated to Shanghai Jiaotong University School of Medicine
    • Beijing
      • Chaoyang District, Beijing, China
        • The 306th Hospital of PLA
      • Haidian District, Beijing, China
        • Beijing Haidian Maternal&Child Health Hospital
    • Chongqing
      • Yuzhong, Chongqing, China
        • Children's Hospital of Chongqing Medical University
    • Guangdong
      • Dongguan City, Guangdong, China
        • Dongguan People's Hospital
      • Guangzhou, Guangdong, China
        • Nanfang Hospital of Southern Medical University
      • Guangzhou, Guangdong, China
        • The Third Affiliated Hospital of Guangzhou Medical University
      • Guangzhou, Guangdong, China
        • Guangzhou Women And Children's Medical Center
      • Guangzhou, Guangdong, China, 510150
        • The First Affiliated Hospital, Sun Yat-sen University
      • Guangzhou, Guangdong, China
        • Zhu Jiang Hospital of Southern Medical University
      • Shantou, Guangdong, China
        • Shantou Central Hospital
      • Zhongshan, Guangdong, China
        • Zhongshan Bo'ai Hospital
    • Hunan
      • Changsha, Hunan, China
        • Changsha Hospital for Maternal&Child Health Care
    • Jiangsu
      • Nanjing, Jiangsu, China
        • Maternity and Child Health Care Hospital in Jiangsu Province
      • Nanjing, Jiangsu, China
        • Nanjing Maternity and Child Health Care Hospital
      • Suzhou, Jiangsu, China
        • Suzhou Municipal Hospital
    • Sichuan
      • Chengdu, Sichuan, China
        • Chengdu Women & Children Center Hospital
      • Chengdu, Sichuan, China
        • West China Second University Hospital, SCU
    • Tianjin
      • Nankai, Tianjin, China
        • Tianjin First Center Hospital
    • Zhejiang
      • Hangzhou, Zhejiang, China
        • Hangzhou First People's Hospital
      • Ningbo, Zhejiang, China
        • Ningbo Yinzhou People's Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 month to 1 month (Child)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Healthy term infants aged approximately 42 days (range 35 - 49 days) who are brought to the health clinic for their first normally-scheduled well-baby visit (i.e. typically age 42 days in China).

Description

Inclusion Criteria:

  • Healthy, term (37-42 weeks gestation), singleton infant at birth.
  • Post-natal age between 35 and 49 days (date of birth = day 0) at time of study entry.
  • At enrollment, weight-for-age ≥ 5th and ≤ 95th percentile according to World Health Organization growth tables / charts.

Exclusion Criteria:

  • Infants who are consuming any types/brands of formula other than the new study formula (either exclusively or in a mixed feeding regimen) at time of study enrollment.
  • Suspected or documented severe acute or chronic medical or psychiatric condition or laboratory abnormality that may increase the risk associated with study participation or may interfere with the interpretation of study results, and in the judgment of the investigator, would make the infant inappropriate for entry into the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Study formula-fed only
Infants who are exclusively fed the new study formula at time of enrollment
Human milk-fed only
Infants who are exclusively fed human milk at time of enrollment
Mixed-fed using study formula only
Infants who are exclusively fed human milk and the new study formula at time of enrollment

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Infant stool consistency and frequency (assessed using a 3-day stool diary)
Time Frame: Baseline
Baseline
Infant stool consistency and frequency (assessed using a 3-day stool diary)
Time Frame: day 15
day 15
Infant stool consistency and frequency (assessed using a 3-day stool diary)
Time Frame: day 30
day 30
Infant stool consistency and frequency (assessed using a 3-day stool diary)
Time Frame: day 45
day 45

Secondary Outcome Measures

Outcome Measure
Time Frame
Infant gastrointestinal tolerance (assessed using a validated, interviewer-assisted parent questionnaire)
Time Frame: Baseline
Baseline
Infant gastrointestinal tolerance (assessed using a validated, interviewer-assisted parent questionnaire)
Time Frame: day 18
day 18
Infant gastrointestinal tolerance (assessed using a validated, interviewer-assisted parent questionnaire)
Time Frame: day 48
day 48
Infant and parent health-related quality of life (assessed using validated parent questionnaires)
Time Frame: Baseline
Baseline
Infant and parent health-related quality of life (assessed using validated parent questionnaires)
Time Frame: day 48
day 48

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

July 1, 2011

Primary Completion (Actual)

July 1, 2013

Study Completion (Actual)

July 1, 2013

Study Registration Dates

First Submitted

June 8, 2011

First Submitted That Met QC Criteria

June 8, 2011

First Posted (Estimate)

June 10, 2011

Study Record Updates

Last Update Posted (Estimate)

December 24, 2013

Last Update Submitted That Met QC Criteria

December 23, 2013

Last Verified

December 1, 2013

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on Study formula feeding

Subscribe